AhR was found to be constitutively active in advanced prostate cancer cell lines that mimic hormone-refractory prostate cancer, and increased nuclear AHR localization was positively associated with higher tumor grade, poor differentiation, and/or poor prognosis (23). This evidence concerns the gene AHR and neoplasm.